Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty

C H Monsen1, P C Adams, L Badimon

  • 1Mount Sinai School of Medicine, City University of New York.

Zeitschrift Fur Kardiologie
|January 1, 1987
PubMed

Insights

Platelets play a key role in coronary angioplasty complications like acute occlusion and restenosis. Inhibiting platelet activity may reduce these risks after the procedure.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Acute occlusion and restenosis are significant complications following coronary angioplasty.
  • These events affect 3-5% and 13-47% of patients, respectively.
  • Platelet activation and interaction with the injured vessel wall are implicated in their pathogenesis.

Purpose of the Study:

  • To elucidate the role of platelets and rheologic factors in post-angioplasty complications.
  • To investigate the potential of antiplatelet therapy in mitigating these adverse events.

Main Methods:

  • The study reviews the biological response to arterial injury caused by angioplasty.
  • It examines the mechanisms of platelet adhesion, activation, and thrombus formation.
  • Animal models were used to assess the effects of platelet inhibitors.

Main Results:

  • Angioplasty causes superficial and deep arterial injury, leading to platelet deposition and activation.
  • Platelet-derived growth factor contributes to intimal hyperplasia and plaque regrowth.
  • Rheologic factors exacerbate platelet activation and thrombus formation.

Conclusions:

  • Platelet activity and rheologic factors are critical in promoting restenosis and acute occlusion.
  • Platelet inhibitor drugs, combined with heparin, show promise in reducing platelet deposition and acute occlusion in animal models.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...